{
  "main_header": {
    "sid": 1003143,
    "name": "Cian Healthcare",
    "stock_name": "Cian Healthcare",
    "full_name": "Cian Healthcare Ltd",
    "name_url": "stocks-analysis/cian-healthcare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "8.26",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "8.26",
    "mcapval": "20.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 542678,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE05BN01027",
    "curr_date": "Apr 10",
    "curr_time": "",
    "bse_nse_vol": 6000,
    "exc_status": "Active",
    "traded_date": "Apr 10, 2026",
    "traded_date_str": "2026 04 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/cian-healthcare-1003143-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "1003143",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/cian-healthcare-1003143"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "10-Jun-2026",
      "details": "As per the attachment.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "09-Jun-2026",
      "details": "Disclosure pursuant to Regulation 30 of the SEBI Listing Regulations - Notice of Postal Ballot",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of Cian Healthcare Limited Held On May 30 2026- Audited Financial Results",
      "datetime": "30-May-2026",
      "details": "Outcome of the Board Meeting of Cian Healthcare Limited held on May 30 2026- Audited Financial Results (Standalone and Consolidated) for the half-year and Financial Year ended March 31 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News